Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
Bristol-Myers Squibb and Clovis Oncology will collaborate to assess the combination of Opdivo (nivolumab) and Rubraca (rucaparib) in Phase 2 and 3 clinical studies in patients with different cancer types, ... Read more
Targeted photodynamic therapy may be a potential approach to treat prostate cancer, according to the results of a new preclinical study. The study, titled “Characterization of an In-111-labeled anti-PSMA ... Read more
Some patients with localized prostate cancer were seen to benefit from treatment with topsalysin (PRX302) in a small Phase 2a proof-of-concept trial (NCT02499848), according to Sophiris Bio. Findings from the ... Read more
A study supported by Blue Earth Diagnostics showed that physicians can be trained to successfully interpret Axumin PET scan images of patients with suspected recurrence of prostate cancer. Axumin ... Read more
Roche says clinicians can now access its anti-p504 (SP116) antibody to help diagnose men with prostate cancer, representing a new way to detect the disease early using a simple laboratory assay. SP116, ... Read more
The SelectMDx test for prostate cancer reduces overdiagnosis and overtreatment in men at risk of prostate cancer compared to PSA testing alone, MDxHealth announced. By cutting the number of unnecessary ... Read more
Men at low risk of prostate cancer who got radiation therapy with Accuray‘s CyberKnife System were still disease-free after seven years, as were 88.5 percent of men at intermediate risk, concluded a ... Read more